Clinical Trials Browser

Chondrosarcoma × Immune Checkpoint Inhibitors × Clear all

NCT04673942 2024-10-26

BETA-PRIME

Phase 2 Recruiting

Adenoviridae Infections, Chondrosarcoma, Neoplasms, Sarcoma

NCT05193188 2023-02-16

A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Phase 2 Unknown

Chondrosarcoma